MARK PANE: Open Payments
NPI 1801845722 · WINSTON SALEM, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$768 in 32 payments from 11 companies in 2025. Trend: 2023 $43,163 · 2024 $17,363 · 2025 $768
Food & beverage: $768
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 17 | $199 |
| Mallinckrodt Hospital Products Inc. | 1 | $125 |
| EMD Serono, Inc. | 3 | $110 |
| GENZYME CORPORATION | 1 | $103 |
| Boston Scientific Corporation | 1 | $44 |
| MDD US Operations, LLC | 2 | $39 |
| Biogen, Inc. | 2 | $36 |
| ARGENX US, INC. | 1 | $35 |
| Eisai Inc. | 2 | $35 |
| TG Therapeutics, Inc. | 1 | $25 |
Products named: ACTHAR, QULIPTA, UBRELVY, General - Pain Management, VYVGART HYTRULO, Leqembi, BRIUMVI, TYSABRI.
Industry payments across NC — which companies pay providers there.
